News
Study presentation
Switco65+ information
Switco65+ collaborators
How can I collaborate?
Publication
Imprint
Login

Publications

1. On-going nested projects

a)      Polypharmacy is associated with the risk of bleeding in elderly patients with venous thromboembolism (W. Leiss, Bern)
b)      Suboptimal adherence to initial antithrombotic processes of care in elderly patients with venous thromboembolism (A. Stuck, Bern)
c)      Risk of falls and major bleeding in elderly patients with venous thromboembolism receiving anticoagulants (P. Kämpfen, Bern)
d)     Inflammatory biomarkers CCN1, FAP, and CRP in patients with unprovoked VTE in SWITCO65+ (M. Husmann, Zürich)
e)      Inflammatory biomarkers CRP, CCN1 and FAP for risk stratification of VTE recurrence in SWITCO65+ (R. Klingenberg, Zürich)
f)       Prospective comparison of prognostics biomarkers (HsTNT, proBNP, cystatinC) in elderly patients with pulmonary embolism (N. Vuillemier and M. Righini, Genève)
g) Quality of life (QOL) evaluation in elderly patients (M. Méan, Bern)
h) Relation between quality of anticoagulation (TTR) / process of care with quality of life (M. Méan, Bern)
i) Physical activity associated with the risk of bleeding (P. Frey, Bern)

2. 2009

Venous thromboembolism in the elderly. Méan M, Aujesky D., Rev Med Suisse. 2009 Oct 28; 5(223):2142-4, 2146.French.

3. 2010

The inter-rater reliability of the Pulmonary Embolism Severity Index. Fraga M, Taffé P, Méan M, Hugli O, Witzig S, Waeber G, Aujesky D. Thromb Haemost. 2010 Dec;104(6):1258-62.

4. 2011

Prospective validation of the Bleeding Risk Index in elderly patients with acute venous thromboembolism (Abstract FM236) N. Scherz, M. Méan Pascual, K. Jäger, B. Frauchiger, M. Egloff, J. Osterwalder, N. Kucher, CM Matter, M. Husmann, M. Aschwanden, A. Angelillo-Scherrer, N. Rodondi, J. Cornuz, JH Beer, M. Banyai, L. Mazzolai, B. Lämmle, O. Hugli, S. Trelle, M. Righini, D. Aujesky. Swiss Medical Forum 2011 May 4; 11(Suppl. 55):14S.

5. 2012

Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism. Zwierzina D, Limacher A, Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Egloff M, Aschwanden M, Mazzolai L, Hugli O, Husmann M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D.

Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism. Scherz N, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Husmann M, Egloff M, Aschwanden M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D.

6. 2013

Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).
Méan M, Aujesky D, Lämmle B, Gerschheimer C, Trelle S, Angelillo-Scherrer A.

The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.
Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Rodondi N, Limacher A, Trelle S, Matter CM, Husmann M, Banyai M, Aschwanden M, Egloff M, Mazzolai L, Hugli O, Bounameaux H, Aujesky D.